Catalyst

Slingshot members are tracking this event:

OPKO (OPK) Announces U.S. Launch of RAYALDEE

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
OPK

100%

Additional Information

Additional Relevant Details The product will be available nationwide at retail pharmacies as early as Wednesday, November 30, 2016.
The U.S. launch of RAYALDEE follows the successful introduction of the product to thousands of nephrologists attending the American Society of Nephrology (ASN) Kidney Week Meeting last week in Chicago. RAYALDEE was approved by the U.S. Food and Drug Administration (FDA) on June 17, 2016.
http://investor.opko...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 23, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Rayaldee, U.s Commercial Launch